Our systems are now restored following recent technical disruption, and we’re working hard to catch up on publishing. We apologise for the inconvenience caused. Find out more

Recommended product

Popular links

Popular links


Drugs for the Treatment of Respiratory Diseases

Drugs for the Treatment of Respiratory Diseases

Drugs for the Treatment of Respiratory Diseases

Editors:
Domenico Spina, King's College London
Clive P. Page, King's College London
William J. Metzger, National Jewish Medical and Research Centre, Denver
Brian J. O'Connor, King's College London
Peter K. Jeffery, Peter J. Barnes, Domenico Spina, Clive P. Page, Brian J. O'Connor, Jeremy M. Segal, Nicholas J. Gross, Mazakazu Ichinose, Paul M. O'Byrne, N. A. Jones, Ahmed Z. El-Hashim, Pierangelo Geppetti, Lawrence G. Garland, Alan G. Lamont, Brydon L. Bennett, Yoshitaka Satoh, Alan J. Lewis, Joseph P. Lynch III, Michael Keane, Athol U. Wells, Mario Cazzola, Maria G. Matera, Robert Wilson, R. Gary, G. Ruiz, Hilary Wyatt, John F. Price, Sanjay Mehta, David G. McCormack, Tarek Saba, Andrew Peacock, Norbert F. Voelkel, M. W. Geraci, S. Abman, Ignacio I. Wistuba, Adi F. Gazdar, Desmond N. Carney, John J. Adcock, Peter V. Dicpinigaitis
Published:
March 2003
Availability:
Available
Format:
Hardback
ISBN:
9780521773218

Looking for an examination copy?

If you are interested in the title for your course we can consider offering an examination copy. To register your interest please contact [email protected] providing details of the course you are teaching.

$414.00
USD
Hardback
$414.00 USD
eBook

    Millions of people are affected by these diseases, and the re-emergence of tuberculosis and increase in asthma in certain populations underline the importance of finding effective treatments. The demographice make this a critical time to identify novel strategies to prevent and treat these increasingly common diseases. The volume surveys and evaluates the drug treatments available for the main categories of lung diseases, including asthma, tuberculosis, smoking disorders, lung cancer, and respiratory infections.

    • First comprehensive survey of established and novel drug treatments for all categories of respiratory diseases
    • The re-emergence and increased prevalence of some of these diseases makes this publication more timely than ever
    • An essential source of reference for all health professionals looking after patients with respiratory diseases

    Reviews & endorsements

    "...a welcome addition to any pulmonologist's reference library." Respiratory Care

    "There are very few similar textbooks on this topic that provide this degree of depth and a current view of drug therapy of respiratory diseases...this is a very good text, most appropriate for sophisticated clinicians and researchers who seek to achieve great depth in their understanding of the basic and clinical pharmacology of drugs used in the treatment of respiratory diseases." Annals of Pharmacotherapy

    "[T]his book is clearly written and produced and unusually well illustrated...extremely useful..." Pharmaceutical Journal

    See more reviews

    Product details

    March 2003
    Hardback
    9780521773218
    612 pages
    256 × 195 × 38 mm
    1.682kg
    108 b/w illus. 15 colour illus. 57 tables
    Available

    Table of Contents

    • Part I. Asthma and COPD:
    • 1. Pathology of asthma and COPD Peter K. Jeffery
    • 2. Glucocorticosteroids Peter J. Barnes
    • 3. ß2- adrenoceptor agonists Domenico Spina, Clive P. Page and Brian J. O'Connor
    • 4. Anticholinergic bronchodilators Jeremy M. Segal and Nicholas J. Gross
    • 5. Antiallergic drugs Mazakazu Ichinose
    • 6. Drugs affecting the synthesis and action of leukotrienes Paul M. O'Byrne
    • 7. Theophylline and selective phosphodiesterase inhibitors in the treatment of respiratory disease N. A. Jones, Domenico Spina and Clive P. Page
    • 8. Potential therapeutic effects of potassium channel openers in respiratory diseases Ahmed Z. El-Hashim
    • 9. Tachykinin and kinin antagonists Pierangelo Geppetti
    • 10. Drugs affecting IgE (synthesis inhibitors and monoclonal antibodies) Lawrence G. Garland and Alan G. Lamont
    • 11. Drugs targeting cell signalling Brydon L. Bennett, Yoshitaka Satoh and Alan J. Lewis
    • Part II. Diffuse Parenchymal Lung Disease:
    • 12. Current approaches to the treatment of parenchymal lung diseases Joseph P. Lynch III and Michael Keane
    • 13. Drug treatments of the future in fibrotic lung disease Athol U. Wells
    • Part III. Infection:
    • 14. Current and future management of pneumonia Mario Cazzola and Maria G. Matera
    • 15. Current treatment of chronic bronchial suppuration Robert Wilson
    • 16. Current and future treatment of cystic fibrosis R. Gary, G. Ruiz, Hilary Wyatt and John F. Price
    • Part IV. Pulmonary Vascular Diseases:
    • 17. Pathophysiology of pulmonary vascular disease Sanjay Mehta and David G. McCormack
    • 18. Current treatment of pulmonary vascular diseases Tarek Saba and Andrew Peacock
    • 19. Future treatment of pulmonary vascular diseases Norbert F. Voelkel, M. W. Geraci and S. Abman
    • Part V. Lung Cancer:20. Molecular pathology of lung cancer Ignacio I. Wistuba and Adi F. Gazdar
    • 21. Small cell lung cancer Desmond N. Carney
    • Part VI. Cough:
    • 22. Mechanisms of cough John J. Adcock
    • 23. Current treatment of cough Peter V. Dicpinigaitis.
      Contributors
    • Peter K. Jeffery, Peter J. Barnes, Domenico Spina, Clive P. Page, Brian J. O'Connor, Jeremy M. Segal, Nicholas J. Gross, Mazakazu Ichinose, Paul M. O'Byrne, N. A. Jones, Ahmed Z. El-Hashim, Pierangelo Geppetti, Lawrence G. Garland, Alan G. Lamont, Brydon L. Bennett, Yoshitaka Satoh, Alan J. Lewis, Joseph P. Lynch III, Michael Keane, Athol U. Wells, Mario Cazzola, Maria G. Matera, Robert Wilson, R. Gary, G. Ruiz, Hilary Wyatt, John F. Price, Sanjay Mehta, David G. McCormack, Tarek Saba, Andrew Peacock, Norbert F. Voelkel, M. W. Geraci, S. Abman, Ignacio I. Wistuba, Adi F. Gazdar, Desmond N. Carney, John J. Adcock, Peter V. Dicpinigaitis

    • Editors
    • Domenico Spina , King's College London
    • Clive P. Page , King's College London
    • William J. Metzger , National Jewish Medical and Research Centre, Denver
    • Brian J. O'Connor , King's College London